A national evaluation of the use and survival impact of adjuvant chemotherapy in Stage II colon cancer from the national cancer database.
Thais Reif de PaulaPrakash GorroochurnHillary L SimonEric M HaasDeborah Susan KellerPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2021)
From this dataset, AC was associated with improved OS in low-risk Stage II disease. These findings from a large-scale sample question current guidelines and the need for better risk stratification. Further study with more robust variables is warranted to determine AC best practices.